We are proud to announce that PhenoPath is now a Quest Diagnostics Company.
- About PhenoPath
- Test Menu
- Diagnostic Services
- BioPharma Services
- News & Info
- Contact Us
- Educational Media
PhenoPath, PLLC
Diagnoses you can count on®
PhenoPath’s test menu includes a broad array of state-of-the-art immunohistochemistry, flow cytometry, fluorescence in situ hybridization and molecular assays as well as chromosome analysis.
PhenoPath now offers EGFR mutation testing using cell-free DNA isolated from plasma. Please see the links below for more information:
- PhenoPath's cobas® EGFR Plasma Mutation Test (IVD)
- Plasma cfDNA EGFR Mutation Testing Requisition Form
Please see Biomarker Testing for Checkpoint Inhibitors for more information on PD-L1 22C3, PD-L1 28-8 and PD-L1 SP142.
Latest News
-
PhenoPath launches first-ever NGS assay
Please read the attached letter for additional information.
Read More » -
PhenoPath conference March 7th
Please read the attached letter regarding the PhenoPath conference scheduled for March 7th, 2019
Read More » -
PhenoPath acquired by Quest Diagnostics
Please read the attached letter for an important announcement regarding PhenoPath
Read More »